Delivery Order SPE2DB22D2007-SPE2DB25FH6YN
Award Date
11/13/24
Potential Completion Date
11/14/24
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,308.92, is for the delivery of JANUMET XR 100-1,000 MG TABLET 90S, a prescription medication used to treat type 2 diabetes. This is a firm fixed-price, delivery order contract with a completion date of January 18, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,795.04 firm fixed-price delivery order is for the supply of JANUMET XR 50-1,000 mg tablets, a prescription medication used to treat type 2 diabetes. The award has an ultimate completion date of February 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award, valued at $1,709.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of January 28, 2025 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award. AmerisourceBergen holds...
This federal contract award, valued at $11,711.53, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG tablets, a prescription medication used to treat type 2 diabetes. The contract is a firm-fixed-price Delivery Order, with a completion date of February 11, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,885.75 firm-fixed-price delivery order is for the supply of JANUMET XR 50-1,000 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of October 28, 2024 and was awarded on October 25, 2024. This award is a part of Amerisourcebergen's existing $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 100-1,000 MG tablets, a medication used for the treatment of diabetes. The contract has a ceiling value of $3,299.68 and is a Firm Fixed Price Delivery Order with a completion date of November 18, 2022. The contract is not designated with a set-aside. AmerisourceBergen Drug...
This federal contract award, valued at $1,563.26, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a drug used for diabetes management. The contract is a Firm Fixed Price Delivery Order with a completion date of January 30, 2025. The award does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,384 firm-fixed-price delivery order is for the supply of JANUMET XR 50-1,000 MG TABLET 180S, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of March 18, 2025 and was awarded on March 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $8,503.86, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 100-1,000 MG tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of May 31, 2024 and is a Firm Fixed Price Delivery Order. This contract is part of a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, valued at $1,352.88, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-500 MG TABLET 180S, a medication used for the treatment of diabetes. The contract is a firm fixed-price Delivery Order and has an ultimate completion date of November 8, 2024. The contract is not designated as a set-aside. AmerisourceBergen, the...